title: Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease Burden.
authors.affiliation: Pfizer Inc., GIPB, Groton, Connecticut, USA.
authors.forename: S G
authors.initials: SG
authors.lastname: Terra
authors.affiliation: Pfizer Inc., New York, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Vincent
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000266:history; D055808:Drug Discovery / Q000266:history / Q000639:trends*; D049670:History, 17th Century; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D049690:History, Ancient; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000266:history / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents